Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Arcus Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
RCUS
New York
8731
https://arcusbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Arcus Biosciences Inc
Arcus Biosciences, Inc. (NYSE:RCUS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
- May 12th, 2024 12:33 pm
Arcus Biosciences Surpasses Analyst Revenue Forecasts in Q1 2024
- May 10th, 2024 5:38 pm
Arcus Biosciences First Quarter 2024 Earnings: Beats Expectations
- May 10th, 2024 11:58 am
Arcus Biosciences Announces New Employment Inducement Grants
- May 9th, 2024 8:35 pm
Arcus Biosciences, Inc. (NYSE:RCUS) Q1 2024 Earnings Call Transcript
- May 9th, 2024 7:48 pm
Arcus Biosciences Inc (RCUS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
- May 9th, 2024 7:47 am
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimates
- May 8th, 2024 9:45 pm
Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update
- May 8th, 2024 8:02 pm
Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024
- May 2nd, 2024 8:05 pm
Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- May 2nd, 2024 2:01 pm
Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know
- May 1st, 2024 2:01 pm
Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting
- Apr 24th, 2024 8:00 pm
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update
- Apr 23rd, 2024 8:05 pm
Investors bid Arcus Biosciences (NYSE:RCUS) up US$219m despite increasing losses YoY, taking five-year CAGR to 8.1%
- Apr 1st, 2024 10:15 am
Insider Sell: COO Jennifer Jarrett Sells 11,551 Shares of Arcus Biosciences Inc (RCUS)
- Mar 29th, 2024 11:01 pm
Insider Sell: COO Jennifer Jarrett Sells 13,449 Shares of Arcus Biosciences Inc (RCUS)
- Mar 20th, 2024 11:00 pm
Insider Sell: COO Jennifer Jarrett Sells 58,625 Shares of Arcus Biosciences Inc (RCUS)
- Feb 29th, 2024 8:14 am
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
- Feb 28th, 2024 9:05 pm
Arcus Biosciences, Inc. (NYSE:RCUS) Q4 2023 Earnings Call Transcript
- Feb 22nd, 2024 4:10 pm
Wall Street Analysts Think Arcus Biosciences, Inc. (RCUS) Could Surge 151.61%: Read This Before Placing a Bet
- Feb 22nd, 2024 2:55 pm
Scroll